New Diabetes Treatments-Enhanced blood flow

Three diabetes treatments with entirely new modes of action were approved: exenatide injection for people with type 2 diabetes, pramlintide injection as an add-on to insulin therapy for people with type 1 or type 2 diabetes and Sitagliptin also for people with type 2 diabetes. Some diabetes medications help the pancreas release more insulin (if you have type 2 diabetes), others help cells use insulin better, and others keep the liver from releasing too much glucose. The new treatments focus action on hormones called incretins.
Exenatide injection:

  • is injected twice a day at mealtime
  • is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines
  • improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying
  • leads to weight loss because patients will feel full faster and stop eating
  • can cause nausea

Exenatide extended release  is  injected once per week is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines  that helps to improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying leads to weight loss because patients will feel full faster and stop eating which can cause nausea.

Pramlintide acetate is intended for those with type 1 or type 2 diabetes who use insulin

  • is injected at mealtime
  • is to never mix with insulin in one syringe; which creates the need for an additional injection for the patient
  • used for better glucose control, reduction in blood glucose spikes, reduction in food intake, whichleads to weight loss
  • can cause nausea or hypoglycemia (dangerously low blood glucose)

Sitagliptin Saxagliptin and linagliptin-All three of these pills

  • are taken once a day
  • are for type 2 diabetes
  • do not promote weight gain
  • are often used in combination with metformin
  • have very little, if any, side effects
  • Should be taken with caution for patients with renal disease (dose should be decreased)
  • slows the breakdown of incretins, so insulin is released over a longer period of time

  • Liraglutide Injection
  • Exenatide Injection
  • Exenatide extended release Injection
  • Pramlintide acetate(Mealtime Injection)
  • Sitagliptin and Metformin (Dipeptidyl Peptidase-4 Inhibitors)
  • Saxagliptin and Metformin
  • Linagliptin and Metformin

Related Conference of New Diabetes Treatments-Enhanced blood flow

September 20-21, 2017

International Conference on Diabetes and Diabetic Nursing Care

Charlotte, North Carolina, USA
October 30- November 1, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Chicago, Illinois, USA
December 04-05, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany
March 8-9, 2018

17th Global Diabetes Conference & Nursing Care

Paris, France
March 19-20, 2018

11th Diabetologists Conference

New York, USA
June 11-12, 2018

27th European Diabetes Congress

Rome, Italy
June 18-19, 2018

3rd International Conference on Metabolic Syndrome

Dublin, Ireland
July 9-10, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

New Diabetes Treatments-Enhanced blood flow Conference Speakers

Recommended Sessions

Related Journals

Are you interested in